Clinical Trials Logo

Chronic Phase clinical trials

View clinical trials related to Chronic Phase.

Filter by:
  • None
  • Page 1

NCT ID: NCT03481868 Recruiting - Clinical trials for Chronic Myeloid Leukemia (CML)

EPIgenetics and in Vivo Resistance of Chronic Myeloid Leukemia Stem Cells to Tyrosine Kinase Inhibitors

EPIK
Start date: February 1, 2018
Phase: N/A
Study type: Interventional

Primary objective : To identify epigenetic dysregulations of in vivo TKI-resisting CML cells Hypothesis : An epigenetic dysregulation is involved in the in vivo survival of a CML cell subclone despite the use of TKIs

NCT ID: NCT02398825 Active, not recruiting - Clinical trials for Chronic Myeloid Leukemia

Activity and Risk Profile of Ponatinib in Chronic Phase Patients With Chronic Myeloid Leukemia Resistant to Imatinib

Start date: June 23, 2016
Phase: Phase 2
Study type: Interventional

This study aims at evaluating the efficacy of treatment with ponatinib in patients with chronic myeloid leukemia who are in a chronic phase and who previously received treatment with imatinib but resulted to be resistant to it.